This discovery prompted the inclusion of boys in screening for MECP2 mutations, allowing them to be classified into four categories: severe neonatal encephalopathy and infantile death, typical RTT, less severe neuropsychiatric phenotypes or MECP2 duplication syndrome (table 2) [101–108]. This evidence concerns the gene MECP2 and neonatal encephalopathy.